Proto Script Pharmaceutical Corp. (PSCR) Financial Statements (2024 and earlier)
Company Profile
Business Address |
9830 6TH STREET, SUITE 103 RANCHO CUCAMONGA, CA 91730 |
State of Incorp. | NV |
Fiscal Year End | December 31 |
Industry (SIC) | 733 - Mailing, Reproduction, Commercial Art And Photography, and Stenographic Services (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
9/30/2017 Q3 | 6/30/2017 Q2 | 3/31/2017 Q1 | 12/31/2016 Q4 | 9/30/2016 Q3 | 6/30/2016 Q2 | 5/31/2016 Q4 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 250 | 56 | 4 | 6 | 17 | 12 | |||
Cash and cash equivalents | 250 | 56 | 4 | 6 | 17 | 12 | |||
Receivables | 104 | 105 | 140 | 247 | 213 | ||||
Other current assets | 12 | 35 | 1 | 1 | 2 | ||||
Other undisclosed current assets | (250) | ||||||||
Total current assets: | 116 | 196 | 145 | 254 | 232 | 12 | |||
Noncurrent Assets | |||||||||
Property, plant and equipment | 42 | 33 | 26 | 15 | 13 | ||||
Other noncurrent assets | 7 | ||||||||
Total noncurrent assets: | 50 | 33 | 26 | 15 | 13 | ||||
TOTAL ASSETS: | 166 | 229 | 170 | 269 | 245 | 12 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities, including: | 230 | 183 | 179 | 34 | 33 | 7 | |||
Employee-related liabilities | 37 | 30 | 21 | 19 | 12 | ||||
Accounts payable | 160 | 131 | 157 | 15 | 22 | ||||
Accrued liabilities | 33 | 23 | |||||||
Other undisclosed accounts payable and accrued liabilities | 7 | ||||||||
Debt | 238 | 69 | 51 | 82 | 52 | ||||
Derivative instruments and hedges, liabilities | 466 | 497 | |||||||
Due to related parties | 17 | 17 | 17 | 99 | 82 | ||||
Other liabilities | 127 | 127 | 167 | 76 | 76 | ||||
Other undisclosed current liabilities | 246 | 161 | 75 | ||||||
Total current liabilities: | 1,324 | 1,055 | 490 | 291 | 161 | 89 | |||
Noncurrent Liabilities | |||||||||
Total liabilities: | 1,324 | 1,055 | 490 | 291 | 161 | 89 | |||
Equity | |||||||||
Equity, attributable to parent | (1,158) | (826) | (320) | (22) | 84 | (77) | |||
Preferred stock | 2 | 2 | |||||||
Common stock | 49 | 49 | 344 | 330 | 33 | 3 | |||
Additional paid in capital | 7,246 | 7,246 | 6,953 | 106 | |||||
Retained earnings (accumulated deficit) | (8,455) | (8,123) | (7,617) | (353) | 51 | (186) | |||
Total equity: | (1,158) | (826) | (320) | (22) | 84 | (77) | |||
Other undisclosed liabilities and equity | |||||||||
TOTAL LIABILITIES AND EQUITY: | 166 | 229 | 170 | 269 | 245 | 12 |
Income Statement (P&L) ($ in thousands)Annual | Quarterly
9/30/2017 Q3 | 6/30/2017 Q2 | 3/31/2017 Q1 | 12/31/2016 Q4 | 9/30/2016 Q3 | 6/30/2016 Q2 | 5/31/2016 Q4 | ||
---|---|---|---|---|---|---|---|---|
Revenues (Revenue, Net) | 114 | 138 | 100 | 214 | 132 | |||
Cost of revenue (Cost of Goods and Services Sold) | (84) | (31) | (100) | (39) | (57) | |||
Gross profit: | 30 | 107 | 1 | 174 | 75 | |||
Operating expenses | (274) | (369) | (380) | (174) | (143) | (21) | ||
Other undisclosed operating loss | (9) | |||||||
Operating income (loss): | (244) | (262) | (380) | 0 | (68) | (30) | ||
Nonoperating expense | (88) | (244) | ||||||
Other undisclosed loss from continuing operations before equity method investments, income taxes | (13,769) | |||||||
Income (loss) from continuing operations: | (333) | (506) | (14,149) | 0 | (68) | (30) | ||
Income (loss) before gain (loss) on sale of properties: | (333) | (506) | (14,149) | 0 | (68) | (30) | ||
Net income (loss): | (333) | (506) | (14,149) | 0 | (68) | (30) | ||
Other undisclosed net income attributable to parent | 6,885 | 9 | ||||||
Net income (loss) available to common stockholders, diluted: | (333) | (506) | (7,264) | 0 | (68) | (21) |
Comprehensive Income ($ in thousands)Annual | Quarterly
9/30/2017 Q3 | 6/30/2017 Q2 | 3/31/2017 Q1 | 12/31/2016 Q4 | 9/30/2016 Q3 | 6/30/2016 Q2 | 5/31/2016 Q4 | ||
---|---|---|---|---|---|---|---|---|
Net income (loss): | (333) | (506) | (14,149) | 0 | (68) | (30) | ||
Comprehensive income (loss), net of tax, attributable to parent: | (333) | (506) | (14,149) | 0 | (68) | (30) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.